论文部分内容阅读
目的:比较头孢曲松钠与青霉素钠对心力衰竭伴肺炎患者的临床疗效。方法:选取2016年4—12月间收治的心力衰竭伴肺炎的患者86例临床资料,将其随机分为观察组和对照组(每组43例);观察组患者给予头孢曲松钠静脉滴注治疗,对照组患者给予青霉素钠静脉滴注治疗,比较两组患者治疗后总有效率和治疗前后血氧饱和度(SpO_2)值的差异情况。结果:观察组患者治疗后的总有效率为88.37%高于对照组为62.79%(P<0.05);治疗前两组患者的心率(HR)、呼吸(RR)和SpO_2测得值经组间比较其差异无统计学意义(P>0.05),治疗后观察组患者的HR、RR和SpO_2测得值均优于对照组(P<0.05)。结论:头孢曲松钠用于治疗心力衰竭伴肺炎患者的临床疗效优于青霉素钠,可有效改善了患者的基本生命体征。
Objective: To compare the clinical efficacy of ceftriaxone sodium and penicillin sodium in patients with heart failure and pneumonia. Methods: The clinical data of 86 patients with heart failure and pneumonia admitted from April to December in 2016 were selected and randomly divided into observation group and control group (43 cases in each group). Patients in observation group were given intravenous ceftriaxone sodium Note treatment, control group patients given penicillin sodium intravenous infusion treatment, the two groups were compared the total effective rate and before and after treatment of oxygen saturation (SpO_2) value of the difference. Results: The total effective rate of observation group after treatment was 88.37%, which was significantly higher than that of control group (62.79%, P <0.05). The heart rate (HR), respiration (RR) The difference was not statistically significant (P> 0.05). After treatment, the measured values of HR, RR and SpO_2 in the observation group were better than those in the control group (P <0.05). Conclusion: The clinical efficacy of ceftriaxone sodium for the treatment of patients with heart failure and pneumonia is better than that of penicillin sodium, which can effectively improve the patients’ basic vital signs.